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Abstract 
Background: Disturbances in the intestinal microbial community (i.e. dysbiosis) or presence of the microbes with 
deleterious effects on colonic mucosa has been linked to the pathogenesis of inflammatory bowel diseases. However 
the role of microbiota in induction and progression of ulcerative colitis (UC) has not yet been fully elucidated.
Methods: Three lines of human microbiota‑associated (HMA) mice were established by gavage of colon biopsy 
from three patients with active UC. The shift in microbial community during its transferring from humans to mice was 
analyzed by next‑generation sequencing using Illumina MiSeq sequencer. Spontaneous or dextran sulfate sodium 
(DSS)‑induced colitis and microbiota composition profiling in germ‑free mice and HMA mice over 3–4 generations 
were assessed to decipher the features of the distinctive and crucial events occurring during microbial colonization 
and animal reproduction.
Results: None of the HMA mice developed colitis spontaneously. When treated with DSS, mice in F4 generation 
of one line of colonized mice (aHMA) developed colitis. Compared to the DSS‑resistant earlier generations of aHMA 
mice, the F4 generation have increased abundance of Clostridium difficile and decrease abundance of C. symbiosum in 
their cecum contents measured by denaturing gradient gel electrophoresis and DNA sequencing.
Conclusion: In our study, mucosa‑associated microbes of UC patients were not able to induce spontaneous colitis in 
gnotobiotic BALB/c mice but they were able to increase the susceptibility to DSS‑induced colitis, once the potentially 
deleterious microbes found a suitable niche.
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Background
Crohn’s disease (CD) and ulcerative colitis (UC), the two 
major types of inflammatory bowel disease (IBD), are 
characterized by chronic relapsing inflammation of the 
gastrointestinal tract. This inflammation is a result of an 
aberrant immune response to antigens of resident gut 
microbiota [1, 2]. In spite of intensive research, however, 
the underlying mechanisms are still not fully elucidated. 
It has been proposed that either imbalances in intestinal 
microbiota (dysbiosis) or presence of commensal bacte-
ria with increased virulence could both cause excessive 
immune response to microbiota by penetrating through 
the mucosal barrier and stimulating local and systemic 
immunity [3–5].
The gut microbiota ecology in UC patients is signifi-
cantly different from the microbiota in healthy subjects, 
with typical reduction of diversity among major anaero-
bic species [6–8]. Transfer of this luminal dysbiotic 
microbial community to the germ-free mice renders 
them more susceptible to experimentally-induced intes-
tinal inflammation than similar transfer from healthy 
subjects [9]. Due to the close contact with gut mucosa, 
the adherent microbes may be even more important 
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for disease development. Dominant species of mucosa-
associated bacteria are significantly different from those 
found in feces [10], and patients with UC have more 
bacteria attached to the epithelial surfaces than healthy 
individuals [11, 12]. But whether these alterations are 
cause or a result of the intestinal inflammation is still not 
entirely clear.
To study these mechanisms and to uncover the par-
ticipation of bacteria in the development of inflammatory 
diseases, microbiota analysis is not sufficient and gno-
tobiology has to be employed. In contrast to established 
human disease, host-microbe interactions during early 
stages of the disease development can be studied by using 
animal models of inflammatory diseases in gnotobi-
otic conditions (i.e. in germ-free or artificially colonized 
animals with known microbes). In our previous experi-
ments, acute intestinal inflammation induced by dextran 
sulfate sodium (DSS) was milder in germ-free (GF) mice 
compared to normally colonized mice [13], and the mode 
and timing of the colonization with microbiota modified 
the future immune phenotype of the host [14].
Since the composition and metabolic activities of intes-
tinal microbiota of experimental animals are different 
from that of human gut microbiota [15], microbes rele-
vant to the human disease could be missed by using ani-
mal models. To overcome this issue, GF animals can be 
colonized with human microbiota. These humanized or 
human microbiota-associated (HMA) animals are capa-
ble of maintaining the bacterial community of the human 
gut, thus keeping microbiota composition and its meta-
bolic activities similar to those of the human intestine 
[16, 17]. Therefore, gnotobiotic animals can be used to 
cultivate bacteria that are uncultivable by most conven-
tional methods [18].
In this study, three lines of HMA mice were created 
by colonization of the GF mice with bacteria present in 
colonic biopsies from three patients with active UC. Our 
aim was to test whether the mucosa-associated bacteria 
derived from UC patients could induce spontaneous colitis 
or render the mice more sensitive to DSS-induced colitis. 
The composition of bacterial community in cecum con-
tent of HMA mice was monitored for several generations 
to understand its dynamics with respect to colonization 
at adult age (parental generation) or neonatal mother-to-
offspring (filial generations) mode of colonization.
Results
The inter‑individual variability in biopsy samples
To measure the inter-individual differences among biopsy 
lysates, we estimated the beta diversity metrics using 
unweighted (qualitative) and weighted (quantitative) 
UniFrac. This qualitative analysis showed that biopsy b 
is significantly different from biopsy a and biopsy c and 
biopsy c was not significantly different from biopsy a. 
However, there were no differences among samples in 
quantitative analysis of beta diversity (Table 1). This sug-
gests that abundances of major bacterial taxa are similar 
among all three biopsy samples and low abundance spe-
cies contributed to the difference between biopsy b and 
biopsy a or biopsy c.
The diversity of microbiota is decreased after the 
colonization
GF mice were successfully colonized with bacteria from 
biopsies of three patients with active UC (Fig.  1a, c). 
Microbial community in samples from human biopsies is 
characterized by dominance of one or two bacterial orders, 
Lactobacillales and Enterobacteriales, which comprise 
more than 80 % of identified reads from each community. 
After the transfer of microbiota into the mice, composition 
of communities was shifted, with decrease in abundance of 
Lactobacillales compensated with an increase in other Fir-
micutes, namely with Clostridiales. Moreover, in general 
abundance distribution of bacterial orders in communities 
after the transplant was more evenly distributed but total 
species richness decreased during transfer from humans 
to mice (Fig.  1b). This decrease may be caused either by 
partial unsuitability of recipient niche for the bacterial 
community found in the biopsy samples or by dying of 
less abundant species during the transfer from human to 
mice. The presence and viability of multiple anaerobic and 
aerobic bacteria in biopsies and cecum of parental genera-
tion of HMA was confirmed by cultivation-based methods 
(Table 2) [19–21].
Colonization of GF mice with mucosa‑associated bacteria 
from IBD patients does not lead to spontaneous colitis
To test if bacteria from the UC biopsies can induce gut 
inflammation, each mouse was evaluated for colitis. 
Table 1 Comparison of microbiota composition in biopsies
Biopsies show significant inter-individual differences only in presence of 
low abundance taxa as showed by qualitative (unweighted UniFrac) but 
not abundance-aware (weighted UniFrac) quantitative analysis. Statistically 
significant results are marked with asterisk
Sample 1 Sample 2 P P (Bonferroni 
corrected)
Unweighted UniFrac
 Biopsy c Biopsy a 0.06 0.90
 Biopsy c Biopsy b 0.00* ≤0.01*
 Biopsy a Biopsy b 0.00* ≤0.01*
Weighted UniFrac
 Biopsy c Biopsy a 0.93 1.00
 Biopsy c Biopsy b 0.42 1.00
 Biopsy a Biopsy b 0.70 1.00
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Compared to water-treated GF mice, which remained 
completely healthy, the clinical colitis score (CCS) and 
myeloperoxidase (MPO) were significantly higher in 
water-treated parental and first filial generation (F1) of 
mice colonized with biopsy a (aHMA) (Fig. 2). Increase in 
MPO was also detected in water-treated parental bHMA 
mice, but no histological signs of colitis were observed in 
any group of water-treated HMA mice (Fig. 2c). Similar 
results were found in parental cHMA mice, which did 
not developed colitis either spontaneously or after DSS-
treatment. The cHMA line of mice did not breed beyond 
parental generation and died out. This suggests that the 
mucosa-associated microbiota from patients with active 
UC cannot induce spontaneous colitis in mice, although 
the process of artificial colonization may induces slight 
inflammation of colonic mucosa.
aHMA mice exhibited an increase in DSS‑colitis sensitivity 
whereas bHMA mice failed to develop colitis
When treated with DSS, GF mice developed milder coli-
tis than conventional (CV) mice, suggesting that the pres-
ence of microbiota increased the susceptibility of mice to 
colitis. There was a significant increase in CCS and MPO 
in GF, CV, F1 aHMA, F4 aHMA and F3 bHMA after DSS 
treatment, compared to their littermates treated with 
water (Fig.  2a, b). Compared to F1 aHMA mice, CCS 
and MPO value were higher in F4 aHMA mice though 
the differences in MPO were not statistically significant. 
The typical histopathologic picture of DSS-induced coli-
tis was observed only in GF mice (mild to medium), F4 
aHMA mice (moderate) and CV mice (very severe) with 
a characteristic massive loss of goblet cells and crypts, 
ulceration and inflammatory infiltrate in the lamina 
Fig. 1 Microbiota composition in colonic biopsies of three patients with active ulcerative colitis and cecum content of parental HMA mice, a 
as measured by 16S sequencing. The composition of each sample is based on the RDP taxonomic assignment of the 16S rDNA sequences. The 
phylum and the genus level are shown for the most abundant bacterial groups. b The Chao1 diversity index of human biopsy samples (a, b and c) 
was compared with the diversity index of cecum contents of relevant mice (healthy aHMA, bHMA and cHMA) by two‑tailed paired Student’s t test. 
The black line represent median and the red lines connect the related samples. c DGGE profiles of 16 s rRNA genes amplified from colonic biopsy 
lysates and cecum content of biopsy‑colonized mice. Excised and successfully sequenced bands are identified with red numbers (1–9), see Table 1 
for identification
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propria and submucosa (Fig. 2c). The increase in macro- 
and microscopic signs of colitis in aHMA mice shows an 
increase in DSS-colitis sensitivity over the generations. 
Interestingly both MPO values and CCS in water-treated 
aHMA mice showed a steady decline tendency over gen-
erations. In contrast to aHMA mice, bHMA mice failed 
to develop colitis in all groups of mice throughout the 
generations (Fig. 2a–c).
Production of proinflammatory and regulatory cytokines is 
increased in colitic F4 aHMA mice
The production of proinflammatory cytokines Tumor 
necrosis factor (TNF)-α and Interferon (IFN)-γ in spleen 
cell suspension was higher in DSS-treated F4 aHMA 
mice than that in their healthy littermates (Fig.  3a, b). 
Higher production of TNF-α was also found in DSS-
treated GF or conventional mice, but the levels of IFN-γ 
were not changed. Interleukin (IL)-10, known to regu-
late immune responses [22], was significantly higher in 
DSS-treated F4 aHMA mice when compared to their 
water-treated littermates (Fig. 3c). Interestingly, contrary 
to F4 mice, production of IL-10 was significantly higher 
in water-treated GF mice than in DSS-treated mice. On 
the other hand, no significant differences in cytokines 
production were determined between DSS-treated and 
water-treated bHMA mice. The differences in cytokine 
production between DSS-treated and untreated mice are, 
therefore, only apparent in mice with clear phenotype of 
DSS-induced colitis, such as DSS-treated GF, F4 aHMA 
and CV mice. These results suggest that changes in the 
cytokine pattern reflect more the presence of colitis in 
DSS-treated animals than the differences in microbiota 
that colonize the mice.
HMA mice in the later generation exhibited higher 
biodiversity in intestinal bacterial community
Shannon-Wiener index was used to compare the diversity 
of microbiota in cecum samples from HMA mice. Signifi-
cantly higher diversity was measured in F4 aHMA mice 
and F3 bHMA mice compared to their previous gen-
erations (aHMA: F1 = 1.03 ± 0.03 vs F4 = 1.18 ± 0.06, 
p < 0.05; bHMA: F1 = 1.12 ± 0.03 vs F3 = 1.35 ± 0.09, 
p  <  0.05). Interestingly, there was no significant differ-
ence in diversity between water-treated and DSS-treated 
HMA mice. Four clusters were roughly generated in 
cecum samples in each line of HMA mice and the sam-
ples from the same generation and treatment clustered 
well together (Figs. 4b, 5b).
A predominance of colitis‑associated Clostridium sp. 
was identified in cecum samples of aHMA mice but not 
in bHMA mice
Prominent bands from DGGE profiles (Figs.  4, 5) of 
PCR amplified DNA from cecum content (Additional 
file 1) were identified as Clostridium sp. and Blautia sp. 
in both aHMA and bHMA mice (Table  3). Compared 
with bHMA mice, in which DSS-induced colitis was not 
established, aHMA mice conserved higher richness of 
Clostridium species in their cecum samples (Table  1). 
Substantial amount of C. difficile and C. aurantibutyri-
cum were identified in F4 aHMA mice, in which DSS-
colitis was successfully developed. These mice have 
substantially lower abundance of C. symbiosum com-
pared to healthy F1 aHMA (Fig. 4a), suggesting that this 
microbe has not been successfully transferred to the later 
generation of aHMA mice.
Discussion
Inflammation in patients with UC is usually confined to 
large intestine, characterized by dysbiosis [23]. When 
transferred to GF mice, this dysbiotic microbial com-
munity in UC patients increase susceptibility to DSS-
induced colitis [9]. Luminal microbes forming feces have 
often only indirect contact with inflamed colon mucosa, 
so mucosa-associated bacteria are more likely to be 
Table 2 Bacteria in  the parental HMA mice and  biopsy 
lysates used for  their colonization, as  identified by  enzy-
matic tests and microscopy
Aerobic bacteria Anaerobic bacteria
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involved in UC due to their close proximity to the host 
epithelium. In healthy individuals, gut bacteria are usu-
ally separated from the intestinal mucosa by thick layers 
of mucus [24], thus even methods as sensitive as quan-
titative (q) PCR or Fluorescence in  situ hybridization 
(FISH) is not able to detect any bacteria in most biopsies 
from healthy subjects [11, 25].
In this study, we found that major bacterial taxa are 
similar among all three biopsy samples we used for col-
onization and only low abundance species differ among 
biopsies from UC patients (Table  1). When the micro-
bial community is transferred from human biopsies to 
GF mice, the species richness of this community is sig-
nificantly reduced (Fig. 1b). This may be caused either by 
partial unsuitability of recipient niche for the bacterial 
community or by dying of less abundant species dur-
ing the transfer from human to mice. This methodical 
difficulty could not be fully excluded even when freshly 
collected biopsies were used and their contact with oxy-
gen in the air was minimized.
Colonization of GF mice with mucosa-associated 
microbiota from UC patient a (aHMA mice) increased 
CCS and MPO activity without damage to colon mucosa. 
CCS and MPO gradually decreased in subsequent gen-
erations, which support the notion that lack of exposure 
to microorganism in the early life could interfere with 
the development of immune system and permanently 
alter important immune functions [14]. Therefore, the 
increase in MPO and presence of pasty stool in parental 
aHMA mice appears to be a result of the poorly regu-
lated host-microbe interaction in the ex-GF mice. The 
absence of mucosal damage in healthy HMA mice sug-
gests that the mucosa-associated microbes from patients 
with active UC do not induce colitis when transferred to 
Fig. 2 Macro‑ and microscopic evaluation of DSS induced colitis, as measured by a clinical colitis score, b colonic MPO activity, and c histological 
analysis of the mucosal damage of the colon descendens. The values are expressed as mean (bar) value ± standard deviation (whisker). Each bar 
represents 4– mice and histology (paraffin‑embedded sections stained with haematoxylin and eosin) is from one mouse showing changes typical 
for each group. The numbers represent histological grade and the black bar is 100 µm. *p ≤ 0.05 vs. non‑treated littermates; †p ≤ 0.05, vs. healthy GF 
mice; #p ≤ 0.05, vs. DSS‑treated GF mice; ‡p ≤ 0.05, vs. DSS‑treated CV mice; F1/3/4 1st/3rd/4th filial generation, DSS dextran‑sodium sulfate
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otherwise healthy host. However, this effect cannot be 
fully excluded, e.g. if some rare and strongly damaging 
microbial communities are transferred, due to the low 
number of individual biopsies we tested.
To investigate how the mucosa-associated bacte-
ria increase the sensitivity to colitis, DSS-colitis was 
induced in GF, HMA and CV mice. Colitis was success-
fully induced in GF, F4 aHMA and CV mice with vary-
ing severity; mild-moderate in GF mice, moderate in F4 
aHMA mice and very severe in CV mice. This is in agree-
ment with our previous study showing that GF mice are 
more resistant to acute DSS-induced colitis than CV 
mice [13]. The presence of mild colon inflammation in 
GF mice suggests that microbiota is not indispensa-
ble for colitis development in this model. The absence 
of colitis in DSS-treated parental, F1 aHMA, F1 bHMA 
and F3 bHMA mice clearly shows that microbiota might 
contain certain protective species that actively pro-
tected mice from intestinal inflammation. Their presence 
would explain the failure to induction of DSS-colitis in 
all bHMA mice and in parental and F1 aHMA mice. The 
increase in susceptibility to DSS-induced colitis between 
F1 and F4 aHMA mice suggests that these protective 
bacteria may be lost or that other, potentially harmful 
microbes found suitable niche during natural coloniza-
tion with co-housing. The differences in colitis sensitiv-
ity between both lines and different generations also 
show, that certain specific microbes, and not the pres-
ence of any microbe, is the cause of colitis sensitivity in 
F4 aHMA mice. We did not transfer the microbiota from 
healthy subjects because we expected that these biopsies 
will yield inoculums too low for successful colonization 
with complex microbiota [11, 25]. On the other hand, we 
cannot exclude that similar effects will be observed also 
with mucosa-associated bacteria from healthy subjects.
When we sequenced the bands that were different 
between F1 and F4 aHMA, we found disappearance of C. 
Symbiosum and appearance of C. difficile. C. symbiosum 
Fig. 3 Cytokine production by spleen cells from HMA mice. Each group contained 4–8 mice. a TNF‑α, b IFN‑γ, and c IL‑10 cytokine levels were 
measured in supernatant from spleen cells. Cytokine values are expressed as mean ± standard deviation, *p ≤ 0.05 vs. non‑treated littermates; 
#p ≤ 0.05, vs. DSS‑treated GF mice
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(member of the Clostridium cluster XIVa) is the most 
abundant bacterium found in human gut mucins, where 
it probably protects the mucosa by producing high lev-
els of butyrate [26]. This effect may be responsible for 
the resistance of the F1 aHMA mice to the DSS-induced 
colitis. Disappearance of C. symbiosum during DSS treat-
ment of F1 aHMA mice could be even partially responsi-
ble for the DSS-induced epithelium damage. C. difficile, 
on the other hand, may produce toxins that can damage 
colon mucosa of infected patients [27]. Indeed, there is 
a strong association between UC and colonization with 
this bacterium [19, 20], and this association is not limited 
only to toxin-producing C. difficile [23]. The close associ-
ation of C. difficile with colitis may be responsible for the 
marked increase in susceptibility to DSS-colitis between 
F1 and F4 generations. Since all these microbes could 
not be introduced in other way than with the original 
biopsy, their appearance on DGGE of F4 aHMA suggests 
that they found suitable niche and increased in numbers. 
PCR-DGGE can detect only more dominant species, 
because its detection limit is between 104 and 108 cfu/ml, 
depending on the selected bacterium [28–30]. Reduced 
richness of intestinal microbiota is a common feature in 
UC patients [7, 31–34]. It is interesting that there is no 
significant reduction in biodiversity of microbiota in 
cecum samples of DSS-treated HMA mice compared to 
their healthy littermates. Taking into account that the 
biopsies were taken from patients with active UC, we can 
speculate that the bacteria transferred to mice were well 
adapted to inflammatory environment.
Intestinal inflammation is associated with impaired 
barrier function, which leads to activation of the systemic 
immunity and production of pro-inflammatory cytokines 
[35, 36]. In fact, this activation is less pronounced in 
the mucosal compartment, including mesenteric lymph 
nodes, than in systemic one, due to more active inhibi-
tory mechanisms in the gut [37]. This effect is probably 
caused by the regulatory mechanisms of the mucosal 
immune system [38]. IL-10 is an important anti-inflam-
matory cytokine that regulate the colonic inflammation 
during experimental colitis in the presence of microbiota 
[39, 40]. Therefore, an increased IL-10 production in 
DSS-treated F4 aHMA mice and DSS-treated CV mice 
maybe caused by negative-feedback loop, where immune 
a b
Fig. 4 The differences in cecum microbiota of F1 and F4 aHMA mice. a DGGE profiles of 16 s rRNA genes amplified from cecum content of 
human biopsy A‑associated mice. Each lane (1–21) represents a DNA sample isolated from cecum content of one mouse. Excised and successfully 
sequenced bands are identified with red numbers (8–16), see Table 1 for identification. b Clustering analysis of DGGE banding profiles of cecum 
samples. The dendrogram was generated by using the Wards method from a Pearson correlation matrix. The numbers on the nodes indicate the 
bootstrap values expressed as percentage from 1000 replications
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system regulates the inflammation caused by gut bar-
rier breach. The observed decrease in IL-10 production 
in DSS-treated GF mice may be caused by the immuno-
logical immaturity, indicating that the GF mice do not 
have fully developed regulatory mechanisms on a level of 
innate and adaptive immunity [41, 42].
Conclusions
In summary, we showed that mucosa-associated bac-
teria from colonic biopsy of the patients with active UC 
can increase sensitivity to DSS-induced colitis, although 
not able to induce spontaneous one. The increase in 
DSS-induced colitis severity between earlier and later 
generations of aHMA, together with the appearance of 
C. difficile and disappearance of C symbiosum, suggests 
that change in the relationship between these two par-
ticular microbes, rather than their presence or absence, 
is important for the sensitivity to colitis. Production of 
these “humanized” mice using patient’s biopsy and fol-
lowing the fate of bacteria over generations may bring 
new insights into host-microbe interaction during intes-
tinal inflammation or in other diseases.
Methods
Patients and biopsy
Biopsy was taken from inflamed sites of colon descend-
ens from three patients during routine endoscopic exam-
ination. First patient (a) was 52-year old male, diagnosed 
with active UC with shortened colon, caused by a chronic 
inflammation. Second patient (b) was a 23-year old male, 
diagnosed with very active UC resistant to both mesala-
sine (5-acetylosalycilic acid) and azathioprine treatment. 
Third patient (c) was 28-year old female, diagnosed with 
very active UC with numerous ulcers. Immediately after 
extraction, the biopsies were transferred to the labora-
tory in sterile tubes pre-loaded with Schaedler anaerobe 
broth (Oxoid Ltd, Cambridge, UK) containing 0.05  % 
cysteine-HCl, 10 % glycerol and covered with the layer of 
paraffin to preserve anaerobes.
Animals
GF BALB/c mice (8–10  week-old) were maintained in 
isolators under sterile conditions, supplied with sterile 
water and sterile pellet diet ST-1 (Velaz, Unetice, Czech 
Republic) ad  libitum, to keep them free of live bacteria. 
a b
Fig. 5 The differences in cecum microbiota of F1 and F3 bHMA mice. a DGGE profiles of 16 s rRNA genes amplified from cecum content of 
human biopsy B‑associated mice. Each lane (1–18) represents a DNA sample isolated from cecum content of one mouse. Excised and success‑
fully sequenced bands are identified with numbers (17–24), see Table 1 for identification. b Clustering analysis of DGGE banding profiles of cecum 
samples. The dendrogram was generated by using the Wards method from a Pearson correlation matrix. The numbers on the nodes indicate the 
bootstrap values expressed as percentage from 1000 replications
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The conventional (CV) BALB/c mice on the same diet 
were regularly checked for the absence of potential path-
ogens according to an internationally established stand-
ard (FELASA).
Human biopsy administration and experimental design
Each human biopsy was homogenized with sterile hand 
homogenizer, and 2-month old GF mice were colo-
nized with 0.2 ml of this homogenate in a single gavage, 
which were employed as Parental HMA mice. All biop-
sies were processed immediately after the transport to 
the laboratory and under anaerobic conditions until the 
gavage. Three months later, parental HMA mice were 
divided into three groups; one group was continuing in 
breeding for reproduction; one group was used for colitis 
induction and the other was used as control against colitis 
induced mice. The offsprings of the parental HMA mice 
(F1) and the third (F3) and fourth (F4) generations were 
again divided into three groups as the parental HMA 
mice did. The microbiota composition of the biopsy 
homogenate and cecum content of the parental HMA 
mice (after 3-month colonization of biopsy homogenate) 
Table 3 Phylogenetic affiliation of DNA sequences retrieved from DGGE bands
If the identity of the best match was 97 % or less, two other matches were selected. The sequence number correspond to these in Figs. 1, 4 and 5. (For sequences refer 
to Additional file 1)
Sample No GenBank Accession number Best match Identity (% 
similarity)
Biopsy a 1 NR121743 Streptococcus lutetiensis 99
P aHMA 2 NR118699 Clostridium innocuum 97
NR044648 Eubacterium tortuosum 91
NR113409 Eubacterium dolichum 90
P aHMA 3 NR119035 Clostridium sphenoides 99
P bHMA 4 NR118729 Clostridium oroticum 98
P bHMA 5 NR041960 Blautia luti 98
P bHMA 6 NR036800 Ruminococcus gnavus 100
Biopsy c 7 NC017960 Enterococcus faecium 98
P cHMA 8 NR119085 Clostridium polysaccharolyticum 97
P cHMA 9 AB971793 Clostridium innocuum 98
F1 aHMA 10 NR044715 Clostridium clostridioforme 96
NR036928 Clostridium hathewayi 96
NR118730 Clostridium symbiosum 96
F1 aHMA 11 NR118730 Clostridium symbiosum 99
F1 aHMA 12 NR119217 Blautia producta 99
F1 aHMA 13 NR041960 Blautia luti 100
F1 aHMA 14 NR118729 Clostridium oroticum 97
NR117142 Eubacterium fissicatena 97
NR104803 Eubacterium contortum 97
F1 aHMA 15 NR118729 Clostridium oroticum 96
NR117147 Eubacterium contortum 96
NR117142 Eubacterium fissicatena 96
F4 aHMA 16 No siginificant similarity found
F4 aHMA 17 NR074454 Clostridium difficile 99
F4 aHMA 18 NR044841 Clostridium aurantibutyricum 98
F1 bHMA 19 NR118729 Clostridium oroticum 98
F1 bHMA 20 NR041960 Blautia luti 98
F1 bHMA 21 NR041960 Blautia luti 100
F1 bHMA 22 NR036800 Ruminococcus gnavus 100
F3 bHMA 23 NR118729 Clostridium oroticum 99
F3 bHMA 24 No siginificant similarity found
F3 bHMA 25 NR118729 Clostridium oroticum 98
F3 bHMA 26 NR118729 Clostridium oroticum 99
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were analyzed by microscopic and cultivation methods 
(see Additional file  1: Table S1) and by next-generation 
sequencing (Fig. 1a, b) to analyze the microbiota viability 
and changes in microbiota diversity during the transfer 
from humans to mice. Colitis was induced in GF, HMA 
and CV mice by 7 days lasting exposure to 2.5 % (weight/
volume) dextran sulfate sodium (DSS; Mw = 36–50 kDa; 
ICN Biomedicals, Cleveland, OH, USA) in sterile drink-
ing water similarly, as described earlier [13, 43]. Controls 
received sterile drinking water. 8-week old mice were 
used in all experiments except Parental HMA mice. Dur-
ing the whole duration of these experiments, each line 
of HMA mice was kept in separate isolator to avoid any 
contamination with other microbes. The cHMA line of 
mice did not breed well and it died out shortly after the 
experiment with parental generation.
Microbiota analysis by cultivation analysis and microscopy
The presence of live microbes in the biopsy lysate and 
in cecum content of the colonized mice was analyzed 
by cultivation-dependent methods with subsequent 
microscopic and enzymatic tests. Before plating, the 
whole cecum of colonized mice was removed and gen-
tly vortex in 5  ml of Schaedler broth containing 0.05  % 
cysteine-HCl. The samples were cultivated either aerobi-
cally using, bovine Blood agar, MRS agar with or without 
0.05 % cysteine, Sabouraud agar (all from Oxoid, Hamp-
shire, UK), Endo agar (Merc, Darmstadt, Germany) or 
anaerobically on VL blood agar (Imuna-Pharm, Slovak 
Republic). Next, the individual colonies were separated, 
cultivated and analyzed by microscopy after Gram’s 
staining and by detection of their oxidase (PLIVA-
Lachema Diagnostika, Brno, Czech Republic) and kata-
lase activity. Subsequently, their enzymatic activity was 
determined by oxidative-fermentative test, enterotest, 
anaerotest, en-coccustest or PYRtest (all from PLIVA-
Lachema Diagnostika, Brno, Czech Republic). The soft-
ware TNW® (PLIVA-Lachema Diagnostika, Brno, Czech 
Republic) was used to identify the individual species of 
bacteria (Table 2).
Evaluation of acute colitis
Each mouse was examined on day 8 for stool consist-
ency (solid 0 points, loose stool that do not stick to the 
anus 2 points, and 4 points for liquid stools that stick to 
the anus) and rectal bleeding (none 0, positive guaiacum 
reaction  2 points, and 4 points for gross bleeding), and 
the clinical colitis score (CCS) was determined as a mean 
of these two parameters.
The colon was removed and its distal third was fixed 
in Carnoy’s solution for 30  min, and then transferred 
into 96  % ethanol, embedded in paraffin, sectioned at 
5 μm transversal sections and stained with haematoxylin 
and eosin. Histological grade, ranging from normal (0) 
through borderline (0.5) to extreme colitis (3), was cal-
culated by evaluating the degree of epithelium ulcera-
tion and infiltration of inflammatory cells in each colon 
segment according to a standardized histological scoring 
system [43].
Myeloperoxidase (MPO) measurement
The extent of neutrophil infiltration was quantified by 
measuring MPO activity in the colon tissue homoge-
nate, as described earlier by Krawisz et  al. [44] with 
some modifications. Briefly, 1–2  cm of colon descend-
ens (approximately 50  mg of tissue) was washed in ice-
cold phosphate-buffered saline (PBS) and homogenized 
in 1  ml of potassium buffer (0.05  M KH2PO4, 0.05  M 
K2HPO4, pH =  6.0). After centrifugation at 12,000g for 
30  min 4  °C, the pellet was resuspended in 1  ml 0.5  % 
hexadecyltrimethylammoniumbromide (HETAB) in 
50 mM potassium buffer (pH = 6.0). Next, samples were 
sonificated for 30  s, freeze-thawed three times, sonifi-
cated again and centrifuged at 12,000g for 30  min. The 
supernatant was used for the measurement of the MPO 
activity. All steps of MPO extraction were carried out on 
ice.
MPO activity was measured by incubating 100 μl of the 
sample with 2.9 ml prewarmed 50 mM phosphate buffer 
(pH = 6.0) containing 16.7 % (wt/vol) o-dianisidine and 
0.0006 % H2O2 at 37 °C. The reaction kinetics was meas-
ured at OD 460 nm for 3 min at 30 s intervals. The MPO 
activity is expressed in units (U) per 1 gram of the tissue, 
where 1 U equals the change of OD460 of 1 in 1 min.
Measurement of cytokine production
Single-cell suspensions of spleens were prepared by 
mashing the tissue and passing the cells through the 
70 µm sterile cell strainers (Becton–Dickinson, San Jose, 
CA, USA). After the lysis of red blood cells with ster-
ile ACK lysing buffer (0.1  mM EDTA, 150  mM NH4Cl, 
10  mM KHCO3), and two washes in complete culture 
medium (RPMI 1640 supplemented with 10  % heat 
inactivated FCS, 2  mM-glutamine, 100 U/ml penicil-
lin, 100  mg/ml streptomycin), the cells were seeded 
at 5 ×  106 cells/500  µl of complete medium per well in 
48-well flat bottom plates (Corning; Tewksbury, MA, 
USA) and cultivated for 48 h at 37 °C, 5 % CO2 in humidi-
fied incubator. The cell supernatant was then used for 
determination of IFN-γ, TNF-α and IL-10. The cytokines 
were measured by ELISA kit (R&D Systems; Mineapolis, 
MN, USA).
DNA isolation
Bacterial DNA was isolated from cecum contents of 
HMA mice using ZR fecal Kit™ (Zymo Research, Irvine, 
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CA, USA), according to the manufacturer’s protocol. The 
concentration and quality of isolated DNA was assessed 
by measuring its absorbance at 260 and 280  nm using 
spectrophotometer (NanoDrop Technologies, Inc; Wilm-
ington, DE, USA) and its concentration was adjusted to 
10 ng/μl.
Polymerase chain reaction (PCR) and denaturing gradient 
gel electrophoresis (DGGE)
The sequences of bacterial 16S rRNA genes were ampli-
fied in the DNA isolated from cecum contents of HMA 
mice using the universal bacterial primers 338GC and 
RP534 in a previously described protocol for PCR 
assays (5′-CGC CCG CCG CGC CCC GCG CCC GGC 
CCG CCG CCG CCG CCG CAC TCC TAC GGG 
AGG CAG CAG-3′) and RP534 (5′-ATT ACC GCG 
GCT GCT GG-3′) in a previously described protocol 
for PCR assays [45]. Each PCR mixture contained 2 μl 
of DNA template, 0.5 μl of each primer (10 μM), 15 μl 
of ReadyMix™ Taq PCR Reaction Mix (Sigma-Aldrich, 
Steinheim, Germany), and 12 μl of nuclease-free H2O. 
Samples were initially denatured at 94 °C for 3 min, fol-
lowed by 36 cycles of 1 min at 94 °C, 20 s at 61 °C and 
40  s at 68  °C with final elongation at 68  °C for 7  min. 
Products from PCR were then processed by DGGE 
using the DCode™ Universal Mutation Detection Sys-
tem (Bio-Rad Laboratories, Hercules, CA, USA) on 9 % 
polyacrylamide gel with 35–60  % denaturing gradient, 
as previously described [46]. Gels were stained in 50 ml 
of 1× TAE with SYBR Green I dye (0.001 %) for 30 min 
and visualized by UV light using the Vilber Lourmat 
System (Marne La Vallée, France). Amplicons of inter-
est were cut from the stained polyacrylamide gel by a 
sterile scalpel blade. Sterile distilled H2O (100  μl) was 
added to the excised gel fragment and subject to cen-
trifugation at 10,000 rpm for 10 min to elute DNA. 1 μl 
of this solution was used for amplification with prim-
ers FP341 and RP534 under the same PCR program, 
as mentioned above. The PCR products were purified 
using QIAquick PCR purification kit (Qiagen, Hilden, 
Germany) and sequenced using ABI PRISM® BigDye® 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosys-
tems, Inc, Foster City, CA, USA) with a PCR thermocy-
cler T-personal Combi (Biometra, GmbH, Goettingen, 
Germany). Products from sequencing were subse-
quently purified using BigDye purification kit (Applied 
Biosystems Inc) and analyzed on 3100 Avant Genetic 
Analyser (Applied Biosystems Inc) in the Institute of 
Animal Science sequencing facility (Prague, Czech 
Republic). The sequences were compared to those in 
the GenBank database using the BLASTn algorithm 
[47]. All sequences that did not gave meaningful result 
were excluded from this search.
Scoring and analysis of bands
Scanned gels were analyzed with BioNumerics (ver-
sion 7.1, Applied Maths, Sint-Martens-Latem, Beigium). 
Similarity indices of bands was calculated by using Pear-
son correlation coefficient and displayed graphically as a 
dendrogram [48]. The Shannon-Wiener index of diver-
sity was used as a parameter to determine the diversity 
of taxa present in microbial communities sampled from 
cecum of HMA mice with and without DSS treatment 
according to Konstantinov et al. [49].
Next generation sequencing analysis and bioinformatics
For library preparation V3 and V4 region of 16S rRNA 
was amplified in triplicate PCR reaction using primer 
pair 341F (CCTACGGGNGGCWGCAG) and 806R 
(GGACTACHVGGGTWTCTAAT) to utilize to the 
maximum read length of employed 2  ×  300 pair-end 
sequencing at Illumina MiSeq platform (San Diego, CA, 
USA). Double-indexing was applied to allow for demul-
tiplexing of output reads into original samples. Each PCR 
reaction was prepared in 25  µl volume using premixed 
mastermix (AmpliTaq Gold 360 Master Mix, Thermo 
Fisher Scientific, Waltham, MA, USA) and 0.8  µM of 
each primer following subsequent cycling conditions: ini-
tial denaturation at 95 °C for 3 min following by 35 cycles 
of 30 s at 94 °C, 1 min at 55 °C and 75 s at 72 °C with final 
extension for 10  min at 72  °C followed by hold at 4  °C. 
PCR reactions were checked on agarose gel for presence 
of expected product in samples and its absence in nega-
tive controls. Next, the triplicates from the same template 
reactions were pooled and cleaned using UltraClean htp 
96 well PCR clean-up kit (MoBio, Carlsbad, CA, USA). 
Concentrations of cleaned samples were measured fluo-
rescently with Quant-iT dsDNA Assay kit (Thermo 
Fisher Scientific). Sequencing adapters were ligated to 
the PCR amplicons with the help of TruSeq PCR-Free LT 
Sample preparation Kit following manufacturer instruc-
tions (Illumina, Inc). Next, sample libraries were pooled 
in equimolar concentration to produce final library, 
which was sequenced on Illumina MiSeq instrument at 
Genomics Core Facility, CEITEC (Brno, Czech Republic). 
Negative control sample (water) was run through all pro-
cedures including DNA extraction, library preparation 
and sequencing. Sequencing data were processed using 
QIIME 1.8.0 [50]. Forward and reverse reads were joined 
to create contigs. Afterwards reads were demultiplexed 
in parallel with quality filtering allowing minimal Phred 
quality score of Q20 and maximum number of consecu-
tive low quality base calls of 12 due to the nature of lower 
quality overlaps of pair-end reads. Resulting reads were 
clustered to operational taxonomic units (OTUs) using 
UCLUST with 97  % similarity threshold against bacte-
rial 16S reference database Greengenes gg_13_8 release 
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[51, 52]. Singletons were discarded before producing final 
dataset. Taxonomic assignment of created OTUs was 
performed employing RDP classifier [53]. Finally infor-
mation about read counts for all OTU clusters from all 
samples together with taxonomic information was output 
in OTU table. Taxa detected in negative control sample 
were screened out based on their relative proportional 
abundance. Resampling to the sequencing depth of 8000 
reads per sample was performed to allow comparison of 
beta diversity measures. The quantitative or qualitative 
measures of beta diversity of samples were compared 
using weighted or unweighted UniFrac pairwise dissimi-
larity matrices, respectively [54]. To measure alpha diver-
sity we calculated Chao1 species richness estimators [55]. 
Raw demultiplexed sequencing data, with sample annota-
tions, were submitted to the Short Read Archive (http://
www.ncbi.nlm.nih.gov/Traces/sra/) under the study 
accession number [SRP066136; http://www.ncbi.nlm.nih.
gov/sra/SRP066136].
Statistics
The differences between control group and multiple 
experimental groups (GF vs. all other healthy mice, 
DSS-treated GF mice vs. all other DSS-treated groups of 
mice and DSS-treated CV mice vs. all other DSS-treated 
mice) were analyzed with one-way analysis of variance 
(ANOVA) with Dunnet’s multiple comparison test. Dif-
ferences between DSS-treated mice and their healthy 
littermates or changes in bacteria biodiversity between 
generations were evaluated using an unpaired two-tailed 
Student’s t test. Data were expressed as mean ± standard 
deviation (SD). Differences were considered statistically 
significant at P  <  0.05. GraphPad Prism statistical soft-
ware (version 5.03, GraphPad Software, Inc. La Jolla, CA, 
USA) was used for analyses.
Availability of data and material
The dataset supporting the conclusions of this article is 
available in the Short Read Archive repository, [SRP066136; 
http://www.ncbi.nlm.nih.gov/sra/SRP066136].
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